Galaxy Medicare Stock Price Today (NSE: GML)
Fundamental Score
Galaxy Medicare Share Price Live NSE/BSE & Institutional Fundamental Analysis
Galaxy Medicare share price today is ₹17.60, up +0.00% on NSE/BSE as of 18 March 2026. Galaxy Medicare (GML) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹28.15 (Cr). The 52-week high for GML share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 8.56x, GML is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.46% and a debt-to-equity ratio of 0.19.
Galaxy Medicare Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Galaxy Medicare Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Galaxy Medicare Share Price: A ROCE Efficiency Analysis
The medical equipment and supplies sector is currently experiencing a shift towards remote patient monitoring and personalized medicine, creating opportunities for companies demonstrating efficient capital allocation. This analysis focuses on the efficiency of Galaxy Medicare's operations, specifically through the lens of Return on Capital Employed (ROCE). Currently, the Galaxy Medicare share price stands at ₹19.85. This analysis forms part of a larger, 80-parameter fundamental audit verified by Sweta Mishra, and presents only observations, without providing buy or sell recommendations.
Galaxy Medicare's ROCE of 17.72% is a key indicator of its profitability relative to the capital it has invested. This suggests a reasonable level of efficiency in deploying capital. A higher ROCE generally indicates that the company is generating more profit from each rupee invested in the business. A sustained high ROCE, such as 17.72%, can create a competitive moat. This moat is formed by the company's ability to reinvest profits at attractive rates, generating further value and hindering competitors with lower returns from matching their growth.
When compared to sector peers, a deeper dive into management quality and capital allocation strategies is crucial. For instance,
Choksi Asia may have a different ROCE profile, which may be attributable to differences in management effectiveness in areas such as supply chain management, operational efficiency, or investment decisions. Qualitative factors such as management expertise and strategic vision are crucial in understanding long-term ROCE sustainability.The PE ratio for Galaxy Medicare is 8.56. This indicates the market's current valuation of the company relative to its earnings. While a lower PE ratio may suggest undervaluation, it is crucial to consider it in conjunction with the ROCE, growth prospects, and the company's risk profile. A company with a high ROCE but a low PE might indicate market skepticism about future growth, or potential concerns that are not immediately apparent in the financial statements. Understanding the interplay between these factors offers a more comprehensive view of the potential investment proposition for Galaxy Medicare.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Galaxy Medicare Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GML across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Excellent ROCE Performance (17.72%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 8.56 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (6.97x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.43%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 1.85%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Galaxy Medicare Financial Statements
Comprehensive financial data for Galaxy Medicare including income statement, balance sheet and cash flow
About GML (Galaxy Medicare)
Galaxy Medicare (GML) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹28.15 (Cr). Galaxy Medicare has delivered a Return on Equity (ROE) of 14.46% and a ROCE of 17.72%. The debt-to-equity ratio stands at 0.19, reflecting the company's capital structure. Investors tracking GML share price can monitor key metrics including P/E ratio, promoter holding of 72.43%, and quarterly earnings growth.
Company Details
GML Share Price: Frequently Asked Questions
What is the current share price of Galaxy Medicare (GML)?
As of 18 Mar 2026, 10:15 am IST, Galaxy Medicare share price is ₹17.60. The GML stock has a market capitalisation of ₹28.15 (Cr) on NSE/BSE.
Is GML share price Overvalued or Undervalued?
GML share price is currently trading at a P/E ratio of 8.56x, compared to the industry average of 47.87x. Based on this relative valuation, the Galaxy Medicare stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of GML share price?
The 52-week high of GML share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Galaxy Medicare share price?
Key factors influencing GML share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Galaxy Medicare a good stock for long-term investment?
Galaxy Medicare shows a 5-year Profit Growth of N/A% and an ROE of 14.46%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.19 before investing in GML shares.
How does Galaxy Medicare compare with its industry peers?
Galaxy Medicare competes with major peers in the Medical Equipment & Supplies. Investors should compare GML share price P/E of 8.56x and ROE of 14.46% against the industry averages to determine competitive standing.
What is the P/E ratio of GML and what does it mean?
GML share price has a P/E ratio of 8.56x compared to the industry average of 47.87x. Investors pay ₹9 for every ₹1 of annual earnings.
How is GML performing according to Bull Run's analysis?
GML has a Bull Run fundamental score of 27.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GML belong to?
GML operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Galaxy Medicare share price.
What is Return on Equity (ROE) and why is it important for GML?
GML has an ROE of 14.46%, which shows decent profitability but room for improvement. ROE measures how efficiently Galaxy Medicare generates profits from shareholders capital.
How is GML debt-to-equity ratio and what does it indicate?
GML has a debt-to-equity ratio of 0.19, which indicates conservative financing with low financial risk.
What is GML dividend yield and is it a good dividend stock?
GML offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Galaxy Medicare shares.
How has GML share price grown over the past 5 years?
GML has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GML and why does it matter?
Promoters hold 72.43% of GML shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Galaxy Medicare.
What is GML market capitalisation category?
GML has a market capitalisation of ₹28 crores, placing it in the Small-cap category.
How volatile is GML stock?
GML has a beta of N/A. A beta > 1 suggests the Galaxy Medicare stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GML operating profit margin trend?
GML has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is GML quarterly performance?
Recent quarterly performance shows Galaxy Medicare YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in GML?
GML has FII holding of 0.00% and DII holding of 1.85%. Significant institutional holding often suggests professional confidence in the Galaxy Medicare stock.